Enzaplatovir
Enzaplatovir (BTA-C585) is an orally bioavailable Inhibitor for respiratory syncytial virus (RSV) infection[1].
Product Specifications
CAS Number
[1323077-89-9]
Product Name Alternative
BTA-C585
UNSPSC
12352005
Target
RSV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/enzaplatovir.html
Concentration
10mM
Purity
99.98
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
O=C(C1=CON=C1C)N2[C@](CN3C4=CC=C3)(C(C=C5)=CN=C5C)N(CC2)C4=O
Molecular Formula
C20H19N5O3
Molecular Weight
377.40
References & Citations
[1]Eric A F Simões, et al. Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children. Infect Dis Ther. 2018 Mar;7 (1) :87-120.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items